Clearstead Advisors Portfolio holdings
Clearstead Advisors is an independent investment adviser that began in 1989 as Hartland & Co and was renamed Clearstead in 2018. Its main approach is to spread client portfolios across asset classes, regions, company sizes and styles, while some of its rules-based strategies can move money into money market, gold or investment-grade bond funds as a defense. Through its ClearAccess platform, clients can invest in alternative managers one by one, or through a hedge fund series or a private equity series. In 2026 Clearstead took over the clients of The Clarius Group. Flexpoint Ford holds the majority ownership, with the firm's employees holding the rest.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.47% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2226
Ginkgo Bioworks
DNA
$663M
| $4.53K | ﹤0.01% |
457
+455
| +22,750% | +$3.8K |
2022 Q1
17 quarters
|
|
2227
Bristow Group
VTOL
$1.22B
| $4.5K | ﹤0.01% |
+109
| New | +$4.88K |
2026 Q2
0 quarters
|
|
2228
Telkom Indonesia
TLK
$10.7B
| $4.49K | ﹤0.01% |
334
| – | – |
2025 Q4
2 quarters
|
|
2229
First Bancorp
FBNC
$2.63B
| $4.48K | ﹤0.01% |
+70
| New | +$4.14K |
2026 Q2
0 quarters
|
|
2230
LSI Industries
LYTS
$746M
| $4.44K | ﹤0.01% |
+167
| New | +$3.86K |
2026 Q2
0 quarters
|
|
2231
TKO Group
TKO
$13.2B
| $4.43K | ﹤0.01% |
22
+7
| +47% | +$1.36K |
2023 Q4
10 quarters
|
|
2232
CRISPR Therapeutics
CRSP
$4.83B
| $4.36K | ﹤0.01% |
80
+5
| +7% | +$264 |
2023 Q2
12 quarters
|
|
2233
JFrog
FROG
$10.5B
| $4.36K | ﹤0.01% |
+48
| New | +$3.12K |
2026 Q2
0 quarters
|
|
2234
Franklin Municipal Income ETF
FTMU
$452M
| $4.35K | ﹤0.01% |
549
| – | – |
2025 Q4
2 quarters
|
|
2235
DELISTED
Taylor Morrison
TMHC
| $4.3K | ﹤0.01% |
60
+30
| +100% | +$1.91K |
2023 Q3
11 quarters
|
|
2236
iRhythm Holdings
IRTC
$4.16B
| $4.28K | ﹤0.01% |
+36
| New | +$4.18K |
2026 Q2
0 quarters
|
|
2237
iShares Convertible Bond ETF
ICVT
$7.34B
| $4.26K | ﹤0.01% |
35
-20
| -36% | -$2.32K |
2025 Q4
2 quarters
|
|
2238
Barings BDC
BBDC
$920M
| $4.26K | ﹤0.01% |
+500
| New | +$4.29K |
2026 Q2
0 quarters
|
|
2239
Core & Main
CNM
$8.33B
| $4.25K | ﹤0.01% |
88
+33
| +60% | +$1.63K |
2024 Q3
7 quarters
|
|
2240
Spire
SR
$5.25B
| $4.22K | ﹤0.01% |
54
+39
| +260% | +$3.35K |
2025 Q1
5 quarters
|
|
2241
BGC Group
BGC
$5.24B
| $4.21K | ﹤0.01% |
+394
| New | +$4.41K |
2026 Q2
0 quarters
|
|
2242
TriCo Bancshares
TCBK
$1.71B
| $4.2K | ﹤0.01% |
+78
| New | +$3.95K |
2026 Q2
0 quarters
|
|
2243
Virtus Investment Partners
VRTS
$804M
| $4.16K | ﹤0.01% |
+29
| New | +$4.09K |
2026 Q2
0 quarters
|
|
2244
Tidewater
TDW
$3.93B
| $4.13K | ﹤0.01% |
+62
| New | +$4.92K |
2026 Q2
0 quarters
|
|
2245
IBEX
IBEX
$597M
| $4.13K | ﹤0.01% |
+136
| New | +$4.05K |
2026 Q2
0 quarters
|
|
2246
Workiva
WK
$4.61B
| $4.12K | ﹤0.01% |
+85
| New | +$4.38K |
2026 Q2
0 quarters
|
|
2247
Appian
APPN
$3.49B
| $4.12K | ﹤0.01% |
+180
| New | +$4K |
2026 Q2
0 quarters
|
|
2248
EverQuote
EVER
$855M
| $4.09K | ﹤0.01% |
+172
| New | +$3.15K |
2026 Q2
0 quarters
|
|
2249
Krystal Biotech
KRYS
$8.76B
| $4.09K | ﹤0.01% |
+11
| New | +$3.29K |
2026 Q2
0 quarters
|
|
2250
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.72B
| $4.08K | ﹤0.01% |
86
+21
| +32% | +$987 |
2025 Q4
2 quarters
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,519 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,519 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.